EGFR and neoplasm: Despite broad scientific knowledge about the disease conditions potentially leading to inconclusive results, difficulties exist in the day-to-day medical care to interpret discordances between liquid biopsy tests and SoC procedures performed in tumour tissue, thereby compromising the selection of the best candidates to receive anti-EGFR therapy.